Bevacizumab Antibody | AbD16748_hIgG1

//www.bio-rad-antibodies.com/bevacizumab-antibody-abd16748-higg1-hca184.html?RenderPageSpecific=1
Bevacizumab Antibody | AbD16748_hIgG1 gallery image 1

Human anti bevacizumab specificity ELISA

A microtiter plate was coated overnight using various antigens (A: Human Serum, B: human IgG1/kappa from myeloma plasma, C: Rituximab, D: Ustekinumab, E: Infliximab, F: Adalimumab, G: Alemtuzumab and H: Bevacizumab) as coating components followed by HRP conjugated Human anti Bevacizumab® (HCA184) as detection reagent

Enlarge
Bevacizumab Antibody | AbD16748_hIgG1 gallery image 2

Human anti bevacizumab bridging ELISA

Human anti bevacizumab (HCA182) was used as the coating component followed by human serum spiked with increasing concentrations of bevacizumab (Avastin®). The detection reagent was HRP conjugated Human anti bevacizumab (HCA184)

Enlarge
Bevacizumab Antibody | AbD16748_hIgG1 gallery image 3

Human anti bevacizumab inhibition ELISA

A microtiter plate was coated over night with human VEGF at a concentration of 1 μg/ml. After washing and blocking with PBST+5% BSA, a pre-incubated mixture of bevacizumab (0.3 μg/ml) plus increasing concentrations of human anti bevacizumab (clone AbD16748, HCA184) in the monovalent Fab format was added. Free bevacizumab, still capable of binding to the human VEGF coated plate, was detected using a HRP-conjugated mouse anti human IgG (Fc) specific antibody (MCA647P) and QuantaBlu™ fluorogenic peroxidase substrate. Data is shown as the mean of three measurements

Enlarge
  • Bevacizumab Antibody | AbD16748_hIgG1 thumbnail image 1
  • Bevacizumab Antibody | AbD16748_hIgG1 thumbnail image 2
  • Bevacizumab Antibody | AbD16748_hIgG1 thumbnail image 3
  • Human anti Bevacizumab:HRP
  • Human anti Bevacizumab
(Rated 0.0 out of 5 based on 0 customer reviews)
    Anti-bevacizumab antibody is a recombinant, neutralizing anti-idiotypic antibody in fully human IgG1 format; it is suitable for bioanalytical method development. It can be used as the detection antibody in a PK bridging ELISA with HCA182, and as a reference standard in an ADA bridging ELISA.
    • Product Type
      Monoclonal Antibody
    • Clone
      AbD16748_hIgG1
    • Isotype
      IgG1
    2 Formats Available
      Product CodeApplicationsDatasheetMSDSPack SizeList PriceQuantity
      HCA184PEdatasheet pdfdatasheet pdf0.1 mg
      HCA184P
      HCA184Edatasheet pdfdatasheet pdf0.1 mg
      HCA184
      Summary
      Secondary Antibodies
      Negative Isotype Controls
      Useful Reagents
      Positive Controls
      Histology Controls
      More Images
      References
      Reviews
      -
      • Bevacizumab, also known as Avastin, is a humanized monoclonal antibody (IgG1/kappa) that inhibits angiogenesis by binding to the vascular endothelial growth factor A (VEGF-A). VEGF-A stimulates new blood vessel formation, also in certain diseases, especially in cancer. Avastin is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian. Clinical trials are underway for many other indications.

        Clone AbD16748_IgG1 is an anti-idiotypic antibody that specifically recognises the Avastin humanised monoclonal antibody. This antibody can be used to measure the Avastin levels in serum from patients.

        Additional Bevacizumab (Avastin) antibodies are also available from Bio-Rad.
      • Intended Use
      • Product Form
        Human IgG1 antibody selected from the HuCAL® phage display library and expressed in a human cell line.
        Human IgG1 antibody selected from the HuCAL® phage display library and expressed in a human cell line. This antibody is supplied as a liquid.
      • Reconstitution
      • Preparation
        Purified IgG prepared by affinity chromatography on Protein A
        Purified IgG prepared by affinity chromatography on Protein A
      • Preservative Stabilisers
        0.01% Thiomersal
        0.01% Thiomersal
      • Immunogen
        Bevacizumab
      • Purity
        97.8% (capillary electrophoresis, reducing conditions).
      • Affinity
        The monovalent intrinsic affinity of this antibody was measured as KD=2.1nM by real time, label-free molecular interaction analysis on immobilized Bevacizumab.
      • Approx. Protein Concentrations
        Total protein concentration 0.1 mg/ml
        Total protein concentration 0.5 mg/ml
      • Reagents In The Kit
      • Preparing The Antibody
      • Test Principle
      • Buffer Solution
        Phosphate buffered saline.
        Phosphate buffered saline.
      • Storage
        Store at -70oC.
        Storage in frost-free freezers is not recommended.
        This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
        Store at +4oC or at -20oC if preferred.
        Storage in frost-free freezers is not recommended.
        This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
      • Shelf Life
        12 months from date of despatch.
        12 months from date of despatch.
      • Acknowledgements
        Sold under license of U.S. Patents 6,300,064, 6,696,248, 6,708,484, 6,753,136, European Patent 0,859,841 and corresponding patents. This antibody was developed by Bio-Rad, a wholly owned subsidiary of Bio-Rad Laboratories Inc., Zeppelinstr. 4, 82178 Puchheim, Germany.
        Avastin is a registered trademark of Genetech Inc.
        Sold under license of U.S. Patents 6,300,064, 6,696,248, 6,708,484, 6,753,136, European Patent 0,859,841 and corresponding patents. This antibody was developed by Bio-Rad, a wholly owned subsidiary of Bio-Rad Laboratories Inc., Zeppelinstr. 4, 82178 Puchheim, Germany.
        Avastin is a registered trademark of Genetech Inc.
      • Licensed Use
        For in vitro research purposes and for commercial applications for the provision of in vitro testing services to support preclinical and clinical drug development. Any re-sale in any form or any other commercial application needs a written agreement with Bio-Rad.
      • Regulatory
        For research purposes only
      • This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.

      • Application NameYesNoMin DilutionMax Dilution
        ELISA
      • Application NameYesNoMin DilutionMax Dilution
        ELISA

      • Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
      • Technical Advice
        Recommended protocols and further information about HuCAL recombinant antibody technology can be found in the HuCAL Antibodies Technical Manual
      • Technical Advice
        Recommended protocols and further information about HuCAL recombinant antibody technology can be found in the HuCAL Antibodies Technical Manual
      • Recommended Protocol
      • Recommended Protocol
      • ELISA
        This product may be used in a direct ELISA or as a detection reagent in a sandwich ELISA together with HCA182 as the capture reagent.
        Protocol: PK bridging ELISA to measure free drug
      • ELISA
        This product may be used in a direct ELISA or as a detection reagent in a sandwich ELISA, when conjugated to HRP, together with HCA182 as the capture reagent.
        Protocol: PK bridging ELISA to measure free drug
        This antibody is fully human and can be used as a reference standard in an ADA assay.
        Protocol: ADA bridging ELISA
      • Immunohistology
      • Immunohistology
      • Histology Positive Control Tissue
      • Histology Positive Control Tissue
      • Immunofluorescence
      • Immunofluorescence
      • Western Blotting
      • Western Blotting
      • Instructions For Use
      • Instructions For Use

      Additional Bevacizumab Antibody Formats

      Formats Clone Applications Sizes available
      Bevacizumab Antibody : HRP AbD16748_hIgG1 E 0.1 mg
      Bevacizumab Antibody : Purified AbD16748_hIgG1 E 0.1 mg
      • Copyright © 2016 Bio-Rad Antibodies (formerly AbD Serotec)

      Recommended Secondary Antibody

        Recommended Negative Isotype Control

          Useful Reagents

            DescriptionProduct CodePack SizeApplicationsList PriceQuantity
            Human anti BevacizumabHCA1820.1 mgE
            HCA182
            DescriptionProduct CodePack SizeApplicationsList PriceQuantity
            LYNX Rapid HRP Antibody Conjugation KitLNK005P1 Conjugation For 20mg AntibodyCJ
            LNK005P
            LYNX Rapid HRP Antibody Conjugation KitLNK001P1 Conjugation For 400µg AntibodyCJ
            LNK001P
            LYNX Rapid HRP Antibody Conjugation KitLNK003P1 Conjugation For 4mg AntibodyCJ
            LNK003P
            LYNX Rapid HRP Antibody Conjugation KitLNK006P3 Conjugations For 40µg AntibodyCJ
            LNK006P
            LYNX Rapid HRP Antibody Conjugation KitLNK002P3 Conjugations For 400µg AntibodyCJ
            LNK002P
            LYNX Rapid HRP Antibody Conjugation KitLNK004P5 Conjugations For 4mg AntibodyCJ
            LNK004P
            Human anti BevacizumabHCA1820.1 mgE
            HCA182
            Human anti BevacizumabHCA1850.1 mgE
            HCA185

            Recommended Positive Controls

              Histology Controls

                Write your review

                You may also be interested in...